ClouDr Group Past Earnings Performance

Past criteria checks 0/6

ClouDr Group has been growing earnings at an average annual rate of 35.2%, while the Healthcare industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 31.1% per year.

Key information

35.2%

Earnings growth rate

54.5%

EPS growth rate

Healthcare Industry Growth11.3%
Revenue growth rate31.1%
Return on equity-16.6%
Net Margin-7.0%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Slammed 29% ClouDr Group Limited (HKG:9955) Screens Well Here But There Might Be A Catch

Sep 02
Slammed 29% ClouDr Group Limited (HKG:9955) Screens Well Here But There Might Be A Catch

Take Care Before Jumping Onto ClouDr Group Limited (HKG:9955) Even Though It's 27% Cheaper

Jun 09
Take Care Before Jumping Onto ClouDr Group Limited (HKG:9955) Even Though It's 27% Cheaper

Cautious Investors Not Rewarding ClouDr Group Limited's (HKG:9955) Performance Completely

Apr 24
Cautious Investors Not Rewarding ClouDr Group Limited's (HKG:9955) Performance Completely

ClouDr Group Limited (HKG:9955) Soars 67% But It's A Story Of Risk Vs Reward

Apr 17
ClouDr Group Limited (HKG:9955) Soars 67% But It's A Story Of Risk Vs Reward

ClouDr Group Limited (HKG:9955) Shares Could Be 36% Below Their Intrinsic Value Estimate

Feb 20
ClouDr Group Limited (HKG:9955) Shares Could Be 36% Below Their Intrinsic Value Estimate

An Intrinsic Calculation For ClouDr Group Limited (HKG:9955) Suggests It's 29% Undervalued

Oct 07
An Intrinsic Calculation For ClouDr Group Limited (HKG:9955) Suggests It's 29% Undervalued

Revenue & Expenses Breakdown

How ClouDr Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:9955 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 244,013-2831,07589
31 Mar 243,852-3031,12789
31 Dec 233,691-3231,17988
30 Sep 233,551-4691,26282
30 Jun 233,411-6141,34576
31 Mar 233,199-1,1521,32795
31 Dec 222,988-1,6891,308115
30 Sep 222,738-1,8871,277168
30 Jun 222,430-2,8441,186207
31 Mar 222,093-3,4921,123222
31 Dec 211,757-4,1391,060236
30 Sep 211,513-4,7011,134227
31 Dec 20839-2,867943132
31 Dec 19524-55722424
31 Dec 18250-14010519

Quality Earnings: 9955 is currently unprofitable.

Growing Profit Margin: 9955 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 9955 is unprofitable, but has reduced losses over the past 5 years at a rate of 35.2% per year.

Accelerating Growth: Unable to compare 9955's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 9955 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-16.9%).


Return on Equity

High ROE: 9955 has a negative Return on Equity (-16.62%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 13:26
End of Day Share Price 2025/02/07 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ClouDr Group Limited is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Liping ZhaoChina International Capital Corporation Limited
null nullCMB International Securities Limited
Jessie LuHSBC